Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy?
- 1 October 2023
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (28) , 4462-4464
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumoursNature, 2020
- Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trialThe Lancet Oncology, 2019
- FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1–Selected Patients With NSCLCJournal of Thoracic Oncology, 2018
- Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2018
- Non–small-cell Lung Cancer With Brain Metastasis at PresentationClinical Lung Cancer, 2018
- STAT3 labels a subpopulation of reactive astrocytes required for brain metastasisNature Medicine, 2018
- Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Brain Metastases Working GroupJournal of Clinical Oncology, 2017
- Estimating Survival in Patients With Lung Cancer and Brain MetastasesJAMA Oncology, 2017
- Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trialThe Lancet, 2016
- Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence dataNeuro-Oncology, 2012